FDA.reportPublic FDA data

EPLERENONE

Substance profile for UNII 6995V82D0B, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for EPLERENONE
Structure render from PubChem CID 443872

Substance Identity#

UNII
6995V82D0B
Preferred term
EPLERENONE
Registry number
107724-20-9
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C24H30O6
Chemical structure for EPLERENONE
Structure render from PubChem CID 443872

Chemical And Database Identifiers#

InChIKey
JUKPWJGBANNWMW-VWBFHTRKSA-N
SMILES
COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]34O[C@@H]3C[C@@]5(C)[C@@H](CC[C@@]56CCC(=O)O6)[C@H]14
RxCUI
298869
PubChem
443872
NCIt
C47513
INN ID
7596

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound443872pubchem.ncbi.nlm.nih.gov/compound/443872
PubChem InChIKey SearchJUKPWJGBANNWMW-VWBFHTRKSA-Npubchem.ncbi.nlm.nih.gov/#query=JUKPWJGBANNWMW-VWBFHTRKSA-N
RxNorm298869mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=298869
NCI ThesaurusC47513ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C47513
FDA Substance Registration System6995V82D0Bprecision.fda.gov/uniisearch/srs/unii/6995V82D0B

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
ACTIVE INGREDIENTThese highlights do not include all the information needed to use Eplerenone Tablets safely and effectively. See full prescribing information for Eplerenone Tablets. Initial U.S. Approval: 20022
ACTIVE MOIETYThese highlights do not include all the information needed to use Eplerenone Tablets safely and effectively. See full prescribing information for Eplerenone Tablets. Initial U.S. Approval: 20022
ACTIVE INGREDIENTThese highlights do not include all the information needed to use Eplerenone Tablets safely and effectively. See full prescribing information for Eplerenone Tablets. Initial U.S. Approval: 20021
ACTIVE MOIETYThese highlights do not include all the information needed to use Eplerenone Tablets safely and effectively. See full prescribing information for Eplerenone Tablets. Initial U.S. Approval: 20021
ACTIVE INGREDIENTThese highlights do not include all the information needed to use INSPRA safely and effectively. See full prescribing information for INSPRA. INSPRA (eplerenone) tablet for oral use Initial U.S. Approval: 20021
ACTIVE MOIETYThese highlights do not include all the information needed to use INSPRA safely and effectively. See full prescribing information for INSPRA. INSPRA (eplerenone) tablet for oral use Initial U.S. Approval: 20021
ACTIVE MOIETYEPLERENONE TABLET [EON LABS, INC.]13
ACTIVE INGREDIENTEPLERENONE TABLET [EON LABS, INC.]13
ACTIVE MOIETYEPLERENONE TABLET [UPSHER-SMITH LABORATORIES, INC.]10
ACTIVE INGREDIENTEPLERENONE TABLET [UPSHER-SMITH LABORATORIES, INC.]10
ACTIVE MOIETYEPLERENONE TABLET, FILM COATED [GREENSTONE LLC]10
ACTIVE INGREDIENTEPLERENONE TABLET, FILM COATED [GREENSTONE LLC]10
ACTIVE MOIETYINSPRA (EPLERENONE) TABLET, FILM COATED [G.D. SEARLE LLC DIVISION OF PFIZER INC]10
ACTIVE INGREDIENTINSPRA (EPLERENONE) TABLET, FILM COATED [G.D. SEARLE LLC DIVISION OF PFIZER INC]10
ACTIVE MOIETYEPLERENONE (EPLERENONE ) TABLET [APOTEX CORP]2
ACTIVE INGREDIENTEPLERENONE (EPLERENONE ) TABLET [APOTEX CORP]2
ACTIVE INGREDIENTEPLERENONE TABLET [AMERICAN HEALTH PACKAGING]1
ACTIVE MOIETYEPLERENONE TABLET [AMERICAN HEALTH PACKAGING]1